Wednesday 24 April 2024
Internal Reference Number: FOI_6392
Date Request Received: 08/12/2021 00:00:00
Date Request Replied To: 06/01/2022 00:00:00
This response was sent via: By Email
Request Summary: Treatment of dermatological conditions
Request Category: Companies
| Question Number 1: How many patients were treated in the last 4 months by the Dermatology department with each of the following: • Abrocitinib • Acitretin • Alitretinoin • Azathioprine • Baricitinib • Ciclosporin • Dupilumab • Methotrexate • Mycophenolate mofetil • Pimecrolimus • Tacrolimus ointment • Tralokinumab • Upadacitinib | |
| Answer To Question 1: Abrocitinib 0 Acitretin 20 Alitreinoin 7 Azathioprine 5 Baricitinib 0 Ciclosporin 15 Dupilumab 12 Methotrexate 13 Mycophenolate mofetil 1 Pimecrolimus 8 Tacrolimus ointment 23 Tralokinumab 0 Upadacitinib 0 | |
| Question Number 2: How many patients were treated in the last 4 months with phototherapy (UVB or PUVA) for: • Atopic Dermatitis • Psoriasis | |
| Answer To Question 2: 22 psoriasis and 14 dermatitis. | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
